ORIFARM GROUP A/S — Credit Rating and Financial Key Figures

ORIFARM GROUP A/S (CVR number: 27347282) is a company from ODENSE. The company reported a net sales of 3.8 mEUR in 2024, demonstrating a growth of 3.5 % compared to the previous year. The operating profit percentage was poor at -966.5 % (EBIT: -36.6 mEUR), while net earnings were 3260 kEUR. The profitability of the company measured by Return on Assets (ROA) was 7.1 %, which can be considered decent but Return on Equity (ROE) was 1.1 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 35.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. ORIFARM GROUP A/S's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.